 Matthew Leroue
Concepts (101)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Respiratory Tract Infections | 6 | 2026 | 397 | 1.300 |
Why?
| | Microbiota | 4 | 2026 | 781 | 0.780 |
Why?
| | Cardiopulmonary Bypass | 1 | 2025 | 221 | 0.760 |
Why?
| | Indoles | 1 | 2025 | 501 | 0.670 |
Why?
| | Tobacco Smoke Pollution | 1 | 2023 | 233 | 0.640 |
Why?
| | Respiratory Insufficiency | 2 | 2021 | 326 | 0.630 |
Why?
| | Critical Illness | 8 | 2025 | 891 | 0.540 |
Why?
| | Positive-Pressure Respiration | 1 | 2017 | 112 | 0.500 |
Why?
| | Gastrointestinal Microbiome | 1 | 2025 | 771 | 0.500 |
Why?
| | Noninvasive Ventilation | 1 | 2017 | 62 | 0.500 |
Why?
| | Enteral Nutrition | 1 | 2017 | 216 | 0.450 |
Why?
| | Pneumonia, Ventilator-Associated | 2 | 2025 | 57 | 0.370 |
Why?
| | Critical Care | 1 | 2017 | 695 | 0.350 |
Why?
| | Extracorporeal Membrane Oxygenation | 2 | 2026 | 383 | 0.330 |
Why?
| | Practice Patterns, Physicians' | 1 | 2017 | 1356 | 0.280 |
Why?
| | Intensive Care Units, Pediatric | 3 | 2024 | 285 | 0.270 |
Why?
| | Child | 14 | 2026 | 22633 | 0.250 |
Why?
| | Infant | 8 | 2026 | 10034 | 0.240 |
Why?
| | Molecular Epidemiology | 1 | 2026 | 73 | 0.230 |
Why?
| | Central Venous Catheters | 2 | 2024 | 52 | 0.230 |
Why?
| | Indoleacetic Acids | 1 | 2025 | 10 | 0.230 |
Why?
| | Carrier State | 1 | 2026 | 79 | 0.230 |
Why?
| | Bacteriological Techniques | 1 | 2025 | 68 | 0.210 |
Why?
| | Multiplex Polymerase Chain Reaction | 1 | 2025 | 53 | 0.210 |
Why?
| | Catheterization, Central Venous | 2 | 2024 | 122 | 0.210 |
Why?
| | Infection Control | 1 | 2026 | 172 | 0.210 |
Why?
| | Trachea | 1 | 2026 | 261 | 0.210 |
Why?
| | Enoxaparin | 1 | 2024 | 67 | 0.210 |
Why?
| | Pneumonia, Bacterial | 1 | 2025 | 113 | 0.200 |
Why?
| | Bacteria | 3 | 2026 | 889 | 0.200 |
Why?
| | Airway Extubation | 1 | 2024 | 60 | 0.200 |
Why?
| | Cross Infection | 1 | 2026 | 262 | 0.190 |
Why?
| | Cotinine | 1 | 2023 | 79 | 0.190 |
Why?
| | Venous Thrombosis | 1 | 2024 | 194 | 0.180 |
Why?
| | Virus Diseases | 1 | 2024 | 216 | 0.180 |
Why?
| | Smoke | 1 | 2023 | 148 | 0.170 |
Why?
| | Prospective Studies | 5 | 2025 | 7990 | 0.170 |
Why?
| | Prone Position | 1 | 2021 | 24 | 0.170 |
Why?
| | Respiratory Syncytial Virus, Human | 1 | 2022 | 81 | 0.170 |
Why?
| | Respiration, Artificial | 2 | 2023 | 708 | 0.160 |
Why?
| | Patient Positioning | 1 | 2021 | 70 | 0.160 |
Why?
| | Infant, Newborn | 4 | 2025 | 6429 | 0.160 |
Why?
| | Genomics | 1 | 2026 | 834 | 0.160 |
Why?
| | Simulation Training | 1 | 2022 | 134 | 0.160 |
Why?
| | Proteome | 1 | 2024 | 518 | 0.150 |
Why?
| | Anticoagulants | 1 | 2024 | 722 | 0.150 |
Why?
| | Length of Stay | 1 | 2025 | 1337 | 0.150 |
Why?
| | Humans | 18 | 2026 | 144759 | 0.140 |
Why?
| | Intermittent Positive-Pressure Ventilation | 1 | 2018 | 12 | 0.140 |
Why?
| | Cannula | 1 | 2018 | 27 | 0.140 |
Why?
| | Child, Preschool | 6 | 2026 | 11787 | 0.130 |
Why?
| | Pediatrics | 1 | 2026 | 1114 | 0.130 |
Why?
| | Proteomics | 1 | 2024 | 1195 | 0.130 |
Why?
| | International Classification of Diseases | 1 | 2018 | 147 | 0.130 |
Why?
| | Oxygen Inhalation Therapy | 1 | 2018 | 182 | 0.120 |
Why?
| | Hospitals, Pediatric | 1 | 2017 | 556 | 0.100 |
Why?
| | Male | 8 | 2026 | 72315 | 0.100 |
Why?
| | Female | 8 | 2026 | 78271 | 0.090 |
Why?
| | Metagenomics | 2 | 2023 | 181 | 0.080 |
Why?
| | Adolescent | 4 | 2025 | 22428 | 0.080 |
Why?
| | Colorado | 1 | 2017 | 4564 | 0.070 |
Why?
| | Clinical Competence | 2 | 2026 | 1244 | 0.060 |
Why?
| | Case-Control Studies | 2 | 2024 | 3604 | 0.060 |
Why?
| | San Francisco | 1 | 2026 | 60 | 0.060 |
Why?
| | Problem-Based Learning | 1 | 2026 | 98 | 0.060 |
Why?
| | Equivalence Trials as Topic | 1 | 2024 | 36 | 0.050 |
Why?
| | Whole Genome Sequencing | 1 | 2026 | 182 | 0.050 |
Why?
| | Nasopharynx | 1 | 2023 | 73 | 0.050 |
Why?
| | Multicenter Studies as Topic | 1 | 2024 | 405 | 0.050 |
Why?
| | Crowding | 1 | 2023 | 37 | 0.050 |
Why?
| | Academic Medical Centers | 1 | 2026 | 547 | 0.050 |
Why?
| | Bayes Theorem | 1 | 2024 | 433 | 0.050 |
Why?
| | Disease Outbreaks | 1 | 2026 | 422 | 0.050 |
Why?
| | Viral Load | 1 | 2024 | 526 | 0.050 |
Why?
| | Systemic Inflammatory Response Syndrome | 1 | 2023 | 96 | 0.050 |
Why?
| | High-Throughput Nucleotide Sequencing | 1 | 2026 | 549 | 0.050 |
Why?
| | Fellowships and Scholarships | 1 | 2026 | 357 | 0.040 |
Why?
| | Haemophilus influenzae | 1 | 2022 | 67 | 0.040 |
Why?
| | Family Characteristics | 1 | 2023 | 197 | 0.040 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2023 | 983 | 0.040 |
Why?
| | Ultrasonography, Interventional | 1 | 2022 | 160 | 0.040 |
Why?
| | Sequence Analysis, RNA | 1 | 2023 | 442 | 0.040 |
Why?
| | Sensitivity and Specificity | 1 | 2025 | 1985 | 0.040 |
Why?
| | Transcriptome | 1 | 2026 | 1045 | 0.040 |
Why?
| | Retrospective Studies | 1 | 2017 | 17066 | 0.040 |
Why?
| | Gene Expression Profiling | 1 | 2026 | 1782 | 0.040 |
Why?
| | RNA, Ribosomal, 16S | 1 | 2021 | 558 | 0.040 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2024 | 1720 | 0.030 |
Why?
| | Adult | 1 | 2021 | 40449 | 0.030 |
Why?
| | Age Factors | 1 | 2024 | 3333 | 0.030 |
Why?
| | Intubation, Intratracheal | 1 | 2018 | 320 | 0.030 |
Why?
| | Intensive Care Units | 1 | 2021 | 916 | 0.030 |
Why?
| | Biomarkers | 1 | 2024 | 4271 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2026 | 6048 | 0.020 |
Why?
| | Databases, Factual | 1 | 2018 | 1486 | 0.020 |
Why?
| | Cohort Studies | 1 | 2022 | 5960 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2018 | 3409 | 0.020 |
Why?
| | Lung | 1 | 2023 | 4109 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2024 | 11679 | 0.020 |
Why?
| | Risk Factors | 1 | 2023 | 10779 | 0.020 |
Why?
| | United States | 1 | 2022 | 15966 | 0.010 |
Why?
|
|
Leroue's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|